Investigation of common variable immunodeficiency patients and healthy individuals using autoimmune lymphoproliferative syndrome biomarkers

Human Immunology

Volumn 74, Issue 12, 2013, Pages 1531-1535

  Roberts, C A ^a   Ayers, L ^a   Bateman, E A L ^a   Sadler, R ^a   Magerus Chatinet, A ^b,c   Rieux Laucat, F ^b,c   Misbah, S A ^d   Ferry, B L ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYANOCOBALAMIN; INTERLEUKIN 10; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; AGED; ARTICLE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPENIA; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEQUENCE ANALYSIS; VITAMIN BLOOD LEVEL;

ALPS; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; CD3+TCRΑΒ+CD4-CD8- DOUBLE NEGATIVE T CELL; COEFFICIENT OF VARIATION; COMMON VARIABLE IMMUNODEFICIENCY; CV; CVID; SCD95L; SOLUBLE CD95 LIGAND; T CELL RECEPTOR; TCR; TCRΑΒ+ DNT;

ADULT; AGED; ANTIGENS, CD95; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COMMON VARIABLE IMMUNODEFICIENCY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MUTATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 84888197680     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.08.266     Document Type: Article

References (20)

1. Sneller M.C., Wang J., Dale J.K., Strober W., Middelton L.A., Choi Y., et al. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 1997, 89:1341.
2. Dowdell K.C., Niemela J.E., Price S., Davis J., Hornung R.L., Oliveira J.B., et al. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood 2010, 115:5164.
3. Oliveira J.B., Bleesing J.J., Dianzani U., Fleisher T.A., Jaffe E.S., Lenardo M.J., et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 2010, 116:e35.
4. Rieux-Laucat F., Blachère S., Danielan S., De Villartay J.P., Oleastro M., Solary E., et al. Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant expression of the clinical manifestations. Blood 1999, 94:2575.
5. Holzelova E., Vonarbourg C., Stolzenberg M.-C., Arkwright P.D., Selz F., Prieur A.-M., et al. Autoimmune lymphoproliferative syndrome with somatic FAS mutations. N Engl J Med 2004, 351:1409.
6. Del-Rey M., Ruiz-Contreras J., Bosque A., Calleja S., Gomez-Rial J., Roldan E., et al. A homozygous FAS ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. Blood 2006, 108:1306.
7. Wang J., Zheng L., Lobito A., Chan F.K.-M., Dale J., Sneller M., et al. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999, 98:47.
8. Magerus-Chatinet A., Stolzenberg M.-C., Loffredo M.S., Neven B., Schaffner C., Ducrot N., et al. FAS-L, IL-10, and double-negative CD4-CD8- TCR α/β+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function. Blood 2009, 113:3027.
9. Rensing-Ehl A., Warnatz K., Fuchs S., Schlesier M., Salzer U., Draeger R., et al. Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency. Clin Immunol 2010, 137:357.
10. Campagnoli M.F., Garbarini L., Quarello P., Garelli E., Carando A., Baravalle V., et al. The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients. Haematologica 2006, 91:538.
11. Bleesing J.J.H., Straus S.E., Fleisher T.A. Autoimmune lymphoproliferative syndrome: a human disorder of abnormal lymphocyte survival. Pediatr Clin North Am 2000, 47:1291.
12. Straus S.E., Sneller M., Lenardo M.J., Puck J.M., Strober W. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med 1999, 130:591.
13. Comans-Bitter W.M., de Groot R., van den Beemd R., Neijens H.J., Hop W.C.J., Groeneveld K., et al. Immunophenotyping of blood lymphocytes in childhood. reference values for lymphocyte subpopulations. J Pediatr 1997, 130:388.
14. Rezaei N., Aghamohammadi A., Kardar G., Nourizadeh M., Pourpak Z. T- Helper 1 and 2 cytokine assay in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 2008, 18:449.
15. Pons J., Ferrer J.M., Martínez-Pomar N., Iglesias-Alzueta J., Matamoros N. Costimulatory molecules and cytokine production by T lymphocytes in common variable immunodeficiency disease. Scand J Immunol 2006, 63:383.
16. Holm A.M., Aukrust P., Aandahl E.M., Müller F., Taskén K., Frøland S.S. Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency - involvement of protein kinase A type I. J Immunol 2003, 170:5772.
17. Zhou Z., Huang R., Danon M., Mayer L., Cunningham-Rundles C. IL-10 production in common variable immunodeficiency. Clin Immunol Immunopathol 1998, 86:298.
18. Shivakumar S., Tsokos G.C., Datta S.K. T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol 1989, 143:103.
19. Teachey D.T. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome. Curr Opin Pediatr 2012, 24:1.
20. Teachey D.T., Manno C.S., Axsom K.M., Andrews T., Choi J.K., Greenbaum B.H., et al. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood 2005, 105:2443.